Finance

Lists
7733:TYO
Olympus Corp
2 008,50 JPY
-0,30%
(-6,00) 1D
1 ოქტ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 7733...
Open
2 024 JPY
High
2 024 JPY
Low
1 982 JPY
Mkt. cap
2,24 ტრლ.
Avg. vol.
4,32 მლნ.
Volume
4,52 მლნ.
P/E ratio
28,21
52-wk high
2 210 JPY
52-wk low
1 302 JPY
EPS
71 JPY
Shares outstanding
341,42 მლნ.
No. of employees
28 ათ.
Open
2 024 JPY
High
2 024 JPY
Low
1 982 JPY
Mkt. cap
2,24 ტრლ.
Avg. vol.
4,32 მლნ.
Volume
4,52 მლნ.
P/E ratio
28,21
52-wk high
2 210 JPY
52-wk low
1 302 JPY
EPS
71 JPY
Shares outstanding
341,42 მლნ.
No. of employees
28 ათ.
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
1 საათის წინ
Astera Labs Holders Are Up 98% On A Bet That Got Harder To Ignore
Bloomberg.com
Bloomberg.com
·
36 წუთის წინ
Asian Stocks Eye Rough Start After US Reversal: Markets Wrap
Profile
Olympus Corporation is a Japanese manufacturer of optics and reprography products, headquartered in Hachioji, Tokyo. Olympus was founded on October 12, 1919 as Takachiho Seisakusho by Takeshi Yamashita, initially specializing in microscopes and thermometers, and later in imaging. In 1921, the name Olympus was registered as a trademark. In 1942, the company was renamed Takachiho Optical Industries, and in 1949 it was renamed Olympus Optical Co., Ltd. In 2003, the company adopted its current name, Olympus Corporation. Olympus holds roughly a 70 percent share of the global endoscope market, estimated to be worth approximately US$2.5 billion. As of 2025, endoscopes and related surgical technologies are now Olympus's exclusive product line. It was formerly also a maker of cameras, camera lenses and dictaphones, until it divested this part to OM Digital Solutions in 2020. It divested from its microscopy and scientific imaging division in 2023, selling it to Bain Capital for approximately $3.1 billion; the division operates as Evident Corporation. Wikipedia
About Olympus Corp
CEOიასუო ტაკეუტი
Employees28,1 ათ.
Founded12 ოქტ. 1919
Headquarters-
SectorMedical device
Last report
7 აგვ. 2026
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
240,40 მლრ. / 228,33 მლრ.
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
247,84 მლრ.
261,04 მლრ.
295,28 მლრ.
240,40 მლრ.
Cost of goods sold
86,54 მლრდ.
96,15 მლრდ.
102,52 მლრ.
83,57 მლრდ.
Cost of revenue
86,54 მლრდ.
96,15 მლრდ.
102,52 მლრ.
83,57 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
119,90 მლრ.
125,65 მლრ.
104,14 მლრ.
125,03 მლრ.
Operating expense
127,74 მლრ.
140,86 მლრ.
145,88 მლრ.
126,76 მლრ.
Total operating expenses
214,27 მლრ.
237,01 მლრ.
248,41 მლრ.
210,33 მლრ.
Operating income
33,56 მლრდ.
24,04 მლრდ.
46,88 მლრდ.
30,07 მლრდ.
Other non operating income
-
-
-819,00 მლნ.
-
EBT including unusual items
27,90 მლრდ.
22,13 მლრდ.
27,08 მლრდ.
27,56 მლრდ.
EBT excluding unusual items
27,90 მლრდ.
22,13 მლრდ.
47,09 მლრდ.
27,56 მლრდ.
Income tax expense
7,70 მლრდ.
7,96 მლრდ.
2,26 მლრდ.
8,46 მლრდ.
Effective tax rate
27,61%
35,98%
8,36%
30,69%
Other operating expenses
7,83 მლრდ.
15,21 მლრდ.
6,54 მლრდ.
1,72 მლრდ.
Net income
20,20 მლრდ.
14,17 მლრდ.
24,82 მლრდ.
19,10 მლრდ.
Net profit margin
8,15%
5,43%
8,40%
7,95%
Earnings per share
-
-
-
-
Interest and investment income
3,64 მლრდ.
356,00 მლნ.
3,96 მლრდ.
1,43 მლრდ.
Interest expense
-5,28 მლრდ.
-2,34 მლრდ.
-2,92 მლრდ.
-2,82 მლრდ.
Net interest expenses
-1,64 მლრდ.
-1,99 მლრდ.
1,04 მლრდ.
-1,39 მლრდ.
Depreciation and amortization charges
-
-
35,20 მლრდ.
-
EBITDA
50,30 მლრდ.
41,76 მლრდ.
63,42 მლრდ.
47,38 მლრდ.
Gain or loss from assets sale
-
-
12,08 მლრდ.
-
AI content may include mistakes. Learn more
Google აპები